$259.60
-0.05-0.02%
At close: Nov 13, 4:00 PM EST
$255.00
-4.60-1.77%
After Hours: 5:07 PM EST
Quest Diagnostics Inc (DGX) Stock Price, Quote, News & History
DGXNYSE
Quest Diagnostics tops Q3 estimates, raises full-year 2026 guidance, and addresses an unauthorized Quanum LSM cybersecurity event.
You can purchase shares of Quest Diagnostics (NYSE:DGX) through any online brokerage.
Other companies in Quest Diagnostics’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Guardant Health Inc (NASDAQ:GH) and BrightSpring Health Services Inc (NASDAQ:BTSG).
Quest Diagnostics has a consensus price target of $213.39.
The stock price for Quest Diagnostics (NYSE: DGX) is $255 last updated November 13, 2026 at 5:07 PM EST.
There are no upcoming dividends for Quest Diagnostics.
Quest Diagnostics does not have any upcoming earnings scheduled.
There is no upcoming split for Quest Diagnostics.
Quest Diagnostics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing...
